Tag Archives: Wall Street Journal

October wraps up healthcare IPOs with another strong week as 2018 biotech explosion still on record pace.

The News: The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stages of development…. Read more »

Elizabeth Holmes’ partner in blood-fraud scheme largely anonymous. Theranos–the Movie–already in the works.

The News: Theranos, the humiliated, disintegrating, and allegedly fraud- packed blood-testing startup, is most often related to its founder and CEO, Elizabeth Holmes. But during the rise and fall of… Read more »

Insys attempting “Phoenix” impersonation as key Q1 earnings slated for Tuesday. Analysts say Buy, but is now the time?

The News: A former Insys Therapeutics Inc. (Chandler AZ) sales representative was recently sentenced to six months of home confinement after admitting that she participated in a scheme to pay… Read more »

GOP’s latest health bill looking more like a white flag on Obamacare repeal promise; McCain’s return won’t save McConnell’s maneuvers.

The News: Shortly after Senate Majority Leader Mitch McConnell unveiled a revised bill last Thursday to overhaul the US healthcare system, lawmakers undecided about the proposed changes to Medicaid gathered together… Read more »

Tesaro says it’s for sale, but who can afford it

The News: Just ahead of the year’s biggest download of cancer data, the maker of a closely watched drug has put itself up for sale, according to The Wall Street… Read more »

Mylan’s EpiPen profitable despite recalls, lawsuits; stock price immune to ethics rants

Mylan NV (Amsterdam) is facing a new class-action lawsuit related to the price hikes of it EpiPen devices. The lawsuit was filed in federal court in Tacoma, Washington on Monday… Read more »

Musk’s new AI startup aims at human brain; tech giants already in that space

Entrepreneur Elon Musk has confirmed on via Twitter the launch of a new venture company, called Neuralink, which aims to develop a brain-computer interface. According to people familiar with the matter, the company will pursue what… Read more »

Theranos investors victims of narcissism

On Thursday (March 23, 2017), the Wall Street Journal posted another seminal report from inside the tattered remains of biomedical company Theranos Inc. (Palo Alto CA). The company, which is… Read more »

Icahn’s latest target, Bristol-Myers, may play hard-to-get; unless Pfizer comes a courting

The News: Activist investor Carl Icahn just announced his latest target: Bristol-Myers Squibb Co., reports the Wall Street Journal. Bristol-Myers has been the focus of several activist investors in recent… Read more »